Bill Commons

NY S 9221

substituted

Establishes a medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants test strip program

New York · 2025-2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did NY S 9221 pass?

The current status of NY S 9221 is not known from the official record. Latest recorded action (2026-06-04): SUBSTITUTED BY A9001

What is NY S 9221 about?

Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.

Who sponsors NY S 9221?

Christopher Ryan is the primary sponsor of NY S 9221.

Description

Directs the commissioner of the office of alcoholism and substance abuse services to establish a program for individuals to receive free drug test strips to detect the presence of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants; directs the commissioner of the office of alcoholism and substance abuse services, in cooperation with the commissioner of the department of health, to develop and conduct a public awareness and educational campaign on the dangers of medetomidine, benzodiazepine, nitazenes, and/or other harmful contaminants.

Introduced
—
Latest action
2026-06-04 — SUBSTITUTED BY A9001
Bill type
bill
Last updated
—

Sponsors

  • Christopher Ryanprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-06-04

    SUBSTITUTED BY A9001

  2. 2026-06-04

    ORDERED TO THIRD READING CAL.1742

  3. 2026-06-04

    COMMITTEE DISCHARGED AND COMMITTED TO RULES

    referral-committee

  4. 2026-05-21

    REPORTED AND COMMITTED TO FINANCE

    referral-committee

  5. 2026-02-17

    REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS

    referral-committee

Versions

Documents

Votes

  • Alcoholism And Substance Use Disorders Vote

    2026-05-21 · pass · 7-0

    Member-level votes (7)
    • Erik Bottcher: yes
    • Nathalia Fernandez: yes
    • Pete Harckham: yes
    • Monica Martinez: yes
    • Peter Oberacker: yes
    • Gustavo Rivera: yes
    • Robert Rolison: yes

Related bills

Official source

https://legislation.nysenate.gov/api/3/bills/2025-2026/S9221?summary=&detail=

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changesStatus and relationship changes

Session-wide evidence can include changes to other bills:

Bulk imports for this sessionSession dates and activity

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 9221. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.